Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOncology, Clinical Diagnosis Track

Utility of whole-body bone scintigraphy and SPECT/CT for the differential diagnosis of Ewing sarcomas /PNET and small cell osteosarcomas before neoadjuvant therapysition:relative;top:1.5000pt;mso-text-raise:-1.5000pt;" >Ewing sarcoma /PNET; Small cell osteosarcoma;Bone scintigraphy (BS); SPECT/CT;Dignosis

Rui Yi Tan, Qian Wang, Qi Xiao and Yonglin Pu
Journal of Nuclear Medicine May 2018, 59 (supplement 1) 131;
Rui Yi Tan
2Department of Nuclear Medicine Peking University Peoples Hospital Beijing China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Qian Wang
1Department of Nuclear Medicine Peking University People's Hospital Beijing China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Qi Xiao
4Department of Radiology Washington University Saint Louis MO United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yonglin Pu
3University of Chicago Chicago IL United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

131

Objectives: Microscopically, the Ewing sarcomas /PNET and small cell osteosarcomas shared similar histology with small round cells and spindly cells arranged in diffuse sheets and pre-surgical pathological differential diagnosis is challenging in the absence of the osteogenesis on the core needle biopsy. This study was performed to evaluate the utility of whole-body bone scintigraphy (BS) and SPECT/CT for the differential diagnosis before pre-surgical neoadjuvant therapy.

Methods: We retrospective analyzed baseline whole-body bone scintigraphy (BS) and core needle biopsy results of 85 patients with pathologically diagnosis of Ewing sarcoma /PNET and small cell osteosarcoma from 2009 to 2017. The post-operative pathology was served as gold standard. Results: There were 68 patients with Ewing sarcoma/PNET and 17 patients with small cell osteosarcoma (51 males and 34 females, age range from 2 to 58 years). The tumors involved limbs, axial skeleton and flat bones. For the diagnosis for small cell osteosarcoma, the BS was correct in 76.5 % (13/17) patients as compared with post-operative surgical pathology. Core needle biopsy was correct in 58.8 % (10/17) patients and 5 of the 17 patients were misdiagnosed as Ewing sarcoma /PNET and 2 patients were diagnosed as osteosarcom. When core-needle biopsy was wrong, 6 patients diagnosed correctly by BS and SPECT/CT. For the diagnosis of Ewing sarcoma /PNET, BS was correct in 82.4% (56/68) patients, and the core needle biopsy was correct in 89.7 %(61/68) patients and 7 of the 68 patients were diagnosed as small cell malignant tumors. When core-needle biopsy was ambiguous, 5 patients diagnosed correctly by BS and SPECT/CT.Conclusions: BS and SPECT/CT can supplement core-needle biopsy for the differential diagnosis of Ewing sarcomas /PNET and small cell osteosarcomas before neoadjuvant therapy and surgery.Key words Ewing sarcoma /PNET; Small cell osteosarcoma; Bone scintigraphy (BS); SPECT/CT; Dignosis

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 59, Issue supplement 1
May 1, 2018
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Utility of whole-body bone scintigraphy and SPECT/CT for the differential diagnosis of Ewing sarcomas /PNET and small cell osteosarcomas before neoadjuvant therapysition:relative;top:1.5000pt;mso-text-raise:-1.5000pt;" >Ewing sarcoma /PNET; Small cell os…
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Utility of whole-body bone scintigraphy and SPECT/CT for the differential diagnosis of Ewing sarcomas /PNET and small cell osteosarcomas before neoadjuvant therapysition:relative;top:1.5000pt;mso-text-raise:-1.5000pt;" >Ewing sarcoma /PNET; Small cell osteosarcoma;Bone scintigraphy (BS); SPECT/CT;Dignosis
Rui Yi Tan, Qian Wang, Qi Xiao, Yonglin Pu
Journal of Nuclear Medicine May 2018, 59 (supplement 1) 131;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Utility of whole-body bone scintigraphy and SPECT/CT for the differential diagnosis of Ewing sarcomas /PNET and small cell osteosarcomas before neoadjuvant therapysition:relative;top:1.5000pt;mso-text-raise:-1.5000pt;" >Ewing sarcoma /PNET; Small cell osteosarcoma;Bone scintigraphy (BS); SPECT/CT;Dignosis
Rui Yi Tan, Qian Wang, Qi Xiao, Yonglin Pu
Journal of Nuclear Medicine May 2018, 59 (supplement 1) 131;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oncology, Clinical Diagnosis Track

  • Immunohistochemical analysis of Gastrin-Releasing-Peptide receptor (GRPr) and Prostate-Specific- Membrane Antigen (PSMA) in primary prostate cancer: comparison with radiolabeled GRPr antagonist (68Ga-RM2) PET/CT
  • Relationship between FDG PETCT imaging and CA 125 levels in treated patients with Ovarian cancers - Can FDG PETCT define and predict the disease burden in clinically suspected recurrence ?
  • Cancer-associated fibroblasts enhance tumor 18F-FDG uptake and contribute to the intratumor heterogeneity of SUVmax
Show more Oncology, Clinical Diagnosis Track

Sarcoma/ Melanoma

  • Prediction of Treatment Outcome and Survival Using 18F-FDG PET/CT Radiomic Features and Standard Biomarkers in Patients with Advanced Melanoma Treated Using Dual Immune Checkpoint Inhibitor Therapy
  • Nuclear Medicine Lymphoscintigraphy
  • 18F-FDG PET/CT in primary prostate synovialsarcoma
Show more Sarcoma/ Melanoma

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire